Rating History for Myriad Genetics (MYGN) by Goldman Sachs

More Stocks Rated by Goldman Sachs | Latest Ratings for MYGN
Date Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
4/16/2025 Matthew Sykes Maintain Buy
(N/A)		 14.00
(18.00)		  
 		   Details